Information Journal Paper
APA:
Copy. (2018). Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain. MOLECULAR THERAPY - NUCLEIC ACIDS, 11(-), 79-90. SID. https://sid.ir/paper/704282/en
Vancouver:
Copy. Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain. MOLECULAR THERAPY - NUCLEIC ACIDS[Internet]. 2018;11(-):79-90. Available from: https://sid.ir/paper/704282/en
IEEE:
Copy, “Supplemental Treatment for Huntington's Disease with miR-132 that Is Deficient in Huntington's Disease Brain,” MOLECULAR THERAPY - NUCLEIC ACIDS, vol. 11, no. -, pp. 79–90, 2018, [Online]. Available: https://sid.ir/paper/704282/en